FDA Updates

According to the Centers for Disease Control, adults in the United States have an average of two to three colds per year. Children have even more.

FDA approved Sandoz’s generic version of Copaxone (glatiramer acetate injection) known as Glatopa, making it the first generic version of the drug available for patients with relapsing forms of multiple sclerosis.